Monte Rosa Therapeutics Inc (GLUE)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-24 | B Purchase | Non-Executive Director |
10,000
+inf%
5.84USD 58,383 |
10,000 +inf% | 5.84 | USD 58,383 | |
| 2024-10-30 | 2024-10-29 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
15,600
-1.0%
9.41USD 146,793 |
15,600 -1.0% | 9.41 | USD 146,793 | |
| 2024-10-30 | 2024-10-29 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
52,305
-3.2%
9.08USD 475,008 |
52,305 -3.2% | 9.08 | USD 475,008 | |
| 2024-10-30 | 2024-10-28 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
89,990
-4.3%
9.66USD 869,240 |
89,990 -4.3% | 9.66 | USD 869,240 | |
| 2024-09-24 | 2024-09-20 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
1,132,566
-18.2%
6.53USD 7,395,203 |
1,132,566 -18.2% | 6.53 | USD 7,395,203 | |
| 2024-09-13 | 2024-09-13 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
9,269
-0.1%
6.16USD 57,100 |
9,269 -0.1% | 6.16 | USD 57,100 | |
| 2024-09-13 | 2024-09-12 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
16,047
-0.3%
6.00USD 96,309 |
16,047 -0.3% | 6.00 | USD 96,309 | |
| 2024-09-13 | 2024-09-11 | S Sale |
Versant Venture Capital VI, L.P. Large shareholder |
541,897
-8.0%
6.00USD 3,251,382 |
541,897 -8.0% | 6.00 | USD 3,251,382 | |
| 2024-07-09 | 2024-07-05 | S Sale |
Principal Accounting Officer Officer |
1,610
-10.4%
3.83USD 6,166 |
1,610 -10.4% | 3.83 | USD 6,166 | |
| 2024-06-05 | 2024-06-03 | S Sale |
Principal Accounting Officer Officer |
1,207
-7.2%
4.04USD 4,876 |
1,207 -7.2% | 4.04 | USD 4,876 |